Enzymes Flashcards
Enzyme
protein catalyst offering control in biological processes
4 Enzymatic malfunctions
Gout
Porphyria
Type 1 albinism
Haemophilia A
HIV 1 protease inhibitors
Target for AIDS therapy with drugs: Indinavir Saquinavir Ritonavir Nelfinavir
Binding of enzyme to substrate provides:
Transition state
Enzyme-Substrate binding models
Lock - Key
Induced Fit
DNA topoisomerase inhibitors
Anticancers
Angiotensin converting enzyme inhibitors
Blood pressure
Xanthine oxidase inhibitors
Gout
HIV proteinase inhibitors
Antiviral
Catalase reaction
2 H2O2 2 H2O + O2
Kinetic Experiments
[S] [P] size - DNA restriction nucleases colour - beta-lactamase degrades Nitrocefin which then changes from yellow to red [E] [ES]
First order rate
v = k[A]
Steady State assumption
[ES] constant
Michaelis Menten equation
v= (Vmax [S]) / (Km + [S])
Km
Dissociation constant of ES
- the lower the Km the higher the affinity of enzyme for substrate
Vmax
Maximum catalytic rate at full saturation
- approached asymptotically
Linewaver Burke Plot
reciprocal of MM
Lineweaver Burke equation
1/v = 1/Vmax + Km/Vmax + [S]
y-int on LB plot
1/Vmax
x-int on LB plot
-1/Km
slope of LB plot
m = Km/Vmax
Dihydrofolate reductase
Inhibitor: Methotrexate - used to treat cancer
Substrate: Tetrahydrofolate - role in purine and pyrimidine biosynthesis
Competitive Inhibition
- Inhibitor binds to active site
- Increase of [S] overcomes inhibition
- Vmax stays the same
- Km increased
Non-competitive Inhibition
- Inhibitor binds to allosteric site
- Inhibitor binds to active site permanently
- Increase of [S] can’t overcome inhibition
- Vmax decreases
- Km stays the same